Page 2 - Erics Lander News Today

Verastem, Inc. (NASDAQ:VSTM – Get Rating) has been given a consensus rating of “Moderate Buy” by the seven brokerages that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price objective among […]

Cantor Fitzgerald reissued their overweight rating on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note issued to investors on Monday, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Verastem’s FY2023 earnings at ($0.26) EPS. A number of other equities analysts have also weighed in on the company. StockNews.com initiated coverage on Verastem […]

/PRNewswire/ -- Science for America (SfA), a non-profit "solutions incubator," announced today the release of a white paper: "New Opportunities for Fusion...

Verastem, Inc. (NASDAQ:VSTM – Get Rating) saw a large decline in short interest in April. As of April 15th, there was short interest totalling 1,080,000 shares, a decline of 15.0% from the March 31st total of 1,270,000 shares. Based on an average daily volume of 687,500 shares, the short-interest ratio is presently 1.6 days. Verastem […]

StockNews.com assumed coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. VSTM has been the subject of a number of other research reports. Mizuho started coverage on Verastem in a report on Wednesday, March 29th. They […]

Shares of Verastem, Inc. (NASDAQ:VSTM – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average […]

Shares of Verastem, Inc. (NASDAQ:VSTM – Get Rating) have received a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month target price […]

Should You Buy or Sell Verastem Stock? Get The Latest VSTM Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

StockNews.com initiated coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research report released on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently commented on VSTM. HC Wainwright reiterated a buy rating and set a $3.00 price target […]

Equities research analysts at StockNews.com began coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note issued to investors on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Several other equities analysts also recently commented on VSTM. Mizuho began coverage on shares of Verastem in a research note […]